U nlike focal suppuration, adult bacterial meningitis (ABM) is typically of monomicrobial infection. [1] [2] [3] [4] [5] Previously, only about 1% of overall bacterial meningitis cases were caused by more than one bacterial species, and before 1950, most of the bacterial meningitis with mixed infection occurred in pediatric group. [5] But after 1950, more mixed infection in bacterial meningitis occurred in adult patients, [1, 4, 5] and in recent years, its incidence has increased gradually. In one study of overall ABM reported in 2008 by Chang et al., [1] the incidence of ABM with mixed infection accounted for 8.84% (16/181) , and in their previous study reported in 2000 , [4] they found that 75% (9/12) of ABM cases with mixed infection had a post-neurosurgical (post-NS) state as the underlying condition, and most of the implicated pathogens had a high incidence of antibiotic resistance. The epidemiology of ABM can be changed by several fac-
Original Article

At a Glance Commentary
Scientific background of the subject
Mixed infection in adult bacterial meningitis (ABM), especially in those with a post-neurosurgical (post-NS) state has been rarely examined solely in the literature. In this study we examined the clinical and laboratory characteristics and therapeutic outcome of this specific infectious syndrome.
What this study adds to the field
Mixed infection is not uncommon in post-NS ABM and Gm(-) pathogens have outnumbered the Gm-(+) pathogens as the implicated pathogens of this specific infectious syndrome. A high suspicion of this infectious disease is needed for early identification because its diagnosis can only be confirmed by positive CSF culture.
tors including various time periods of study, geographic distribution, age, race, underlying medical and/or neurosurgical (NS) conditions, means of contraction, status of vaccination, and use of antibiotics in community. [1, 2] This epidemiologic change may influence the choice of appropriate antibiotics which is an important strategy for a successful ABM management. [1, 2, [6] [7] [8] [9] [10] [11] [12] [13] Management of post-NS ABM is a therapeutic dilemma because of its complicated NS procedures, diagnostic confirmation of bacterial meningitis, and choice of appropriate antibiotics, especially when facing the mixed infection state. [1, 4, [14] [15] [16] [17] Therefore, we analyzed the clinical and laboratory characteristics of 18 post-NS ABM cases with mixed infection, collected during a study period of 11 years, in order to offer a better view of this uncommonly reported central nervous system (CNS) infection.
METHODS
The medical and microbiological records of cerebrospinal fluid (CSF) of all adult patients with bacterial meningitis admitted to our hospital from 2000 to 2010 were retrospectively reviewed. Our hospital is the largest teaching hospital in southern Taiwan and is a 2482-bed acute-care teaching hospital providing both primary and tertiary care services. This study was approved by the Ethics Committee of Chang Gung Memorial Hospital (IRB 100-0323C).
In this study, the criteria used for a definite diagnosis of ABM are as follows: [1, 2] (a) age ≥ 17 years; (b) positive CSF culture in patients with clinical presentations of acute bacterial meningitis, including fever, headache, altered consciousness, and seizure; and (c) at least one of the following CSF parameters: (1) a leukocyte count > 0.25 × 10 9 /L with predominant polymorphonuclear cells; (2) a CSF lactate concentration > 3.5 mmol/L; or (3) a glucose ratio (CSF glucose/serum glucose) < 0.4 or CSF glucose concentration < 2.5 mmol/L if no simultaneous blood glucose was determined. Coagulase-negative staphylococci were considered to be pathogenic when positive cultures were noted in ≥ 2 separate CSF studies or one positive CSF culture was obtained from the tip of an indwelling NS device. [17] In this study, "nosocomial" meningitis was defined as a positive bacterial infection not present when the patient was admitted to the hospital, clinical evidence of an infection > 48 h after admission, or clinical evidence of meningitis within 1 month after discharge from the hospital where the patient had received an invasive procedure, especially an NS procedure. Otherwise, the patient was considered to have "community-acquired" infection. Meningitis related to traumatic skull fracture, NS procedure, or any causes of skull defects was classified as "post-NS" form. Otherwise, patients were classified as the "spontaneous" form. Patients were considered to have mixed infection if at least two bacterial organisms were isolated concomitantly from the initial CSF cultures. [4] "Superinfection" in ABM was defined as a condition wherein CSF grew new pathogen(s) during the therapeutic course of existing bacterial meningitis. [15] Both the mixed infection and superinfection were classified in the polymicrobial infection. In this study, the analysis of antibiotic susceptibility was based on the National Committee for Clinical and Laboratory Standards/Clinical and Laboratory Standards (NCCLS/CLS) methods. Intermediate and resistant isolates were considered non-susceptible. [18] In the study period, vancomycin plus a 3 rd or 4 th generation cephalosporin were the initial empiric antibiotics used in the treatment of patients with suspected ABM in our hospital, and the antimicrobial regimen was adjusted subsequently after the culture results were made available.
For comparative analysis, the clinical features of the post-NS ABM patients with mixed infection were compared with those of post-NS ABM patients with single pathogen infection. Meanwhile, the clinical characteristics and laboratory data between the fatal and non-fatal cases of the mixed infection group were also compared. The clinical data including gender, underlying condition, clinical presentations, and therapeutic outcome were analyzed by Fisher's exact test. The data of age, CSF white blood cell count, glucose level, total protein, and lactate were compared using the Mann-Whitney U test. A p < 0.05 was considered statistically significant.
RESULTS
During this study period, a total of 261 ABM cases were identified, and among them, 170 belonged to post-NS meningitis cases. The 170 post-NS ABM cases included 133 cases with a monomicrobial infection and 37 cases with a polymicrobial infection. Among the latter 37 cases, 16 had mixed infection, 19 had superinfection, and 2 had both mixed infection and superinfection, i.e., a total of 18 cases had the condition of post-NS ABM with mixed infection. In this study, the clinical and laboratory characteristics of the 18 post-NS ABM cases with mixed infection were analyzed, and for a comparative purpose, the clinical and laboratory characteristics of the other 133 post-NS ABM cases with monomicrobial infection were also analyzed.
The 18 post-NS ABM cases with mixed infection consisted of 11 men and 7 women, aged 20-77 years (median = 57.5), and their clinical and laboratory information are listed in Table 1 . The underlying NS conditions of these 18 cases of ABM with mixed infection were spontaneous intracranial hemorrhage (ICH) + s/p craniotomy + external ventricular dranage (EVD) in three cases (cases 5, 12, and 17), spontaneous ICH + s/p EVD in two cases (cases 14 and 18), spontaneous ICH + s/p craniectomy + ventriculoperitoneal (VP) shunt + cranioplasty in one case (Case 2), spontaneous ICH + s/p craniectomy + EVD in one case (Case 3), Table 3 . The implicated bacterial strains of the other 133 monomicrobial ABM are also shown in Table 2 , and they included 68 Gm(-) strains and 65 Gm(+) strains. Of the 68 Gm(-) strains, Acinetobacter baumannii (18) was the most common, followed by Klebsiella pneumoniae (11) and Pseudomonas aeruginosa (9) . Of the 65 Gm(+) strains, staphylococcal spp. (45) was the most common, followed by Enterococcus spp. (8) and Streptococcus spp. (7) . As shown in Table 1 , the major antibiotics used for the treatment of these 18 cases of ABM with mixed infection included vancomycin, linezolid, ceftazidime, cefepime, meropenem, and metronidazole, and the main NS procedures that had been undertaken for these 18 post-NS ABM cases with mixed infection included creating new EVD with removal of old VP shunt in five cases (cases 2 Table 4 and no definite prognostic factor was found. In this study, as shown in Table 5 , we also compared the clinical and laboratory characteristics between the ABM with mixed infection and monomicrobial infection, and the result showed that those with monomicrobial infection had a higher CSF white blood cell count (p = 0.014).
DISCUSSION
In a large-scale study of ABM, [2] mixed infection was found in 7% of the patients with nosocomial infection and most of the cases were related to a post-NS state. In this study, 10.6% (18/170) of the post-NS ABM cases had a mixed infection state. Compared with the results of our previous and other large-scale studies of ABM, [1, 2, 4, 5, [19] [20] [21] [22] [23] this figure of incidence of mixed infection is relatively higher and can be related to the increased number of post-NS ABM cases in our hospital. [1] All these may further confirm the finding of previous reports [1, 2, 4, 5, 24] which showed that presence of post-NS condition is the most important preceding event for the development of mixed infection in ABM. As shown in Tables 1, 4 , and 5, the main clinical and laboratory presentations of these 18 cases of ABM with mixed infection were fever (88.9%, 16/18), altered consciousness (38.9%, 7/18), and seizure (27.8%, 5/18), hydrocephalus in 66.7% (12/18) of the neuroimage study, and 77.8% (14/18) had a peripheral leukocytosis; but all these presentations are not unique, and can be found in other groups of ABM. [1, 2, 4, 5, 24] In this study, as shown in Table 5 , the difference between the post-NS ABM with monomicrobial and mixed infection was not distinct although those with monomicrobial infection had a higher CSF white blood cell count. Therefore, the presence of mixed infection in post-NS ABM can only be confirmed by a positive CSF culture and a high suspicion is needed for its identification, especially in those with a preceding post-NS state.
Of the implicated bacterial pathogens of the present 18 post-NS ABM patients with mixed infection, Gm(-) pathogens were the most common (76%, 34/45), followed by Gm(+) pathogens (24%, 11/45). The condition of Gm(+) strains outnumbered by Gm(-) strains as the implicated pathogens of ABM has been noted as an important epidemiolologic change in Taiwan. [1] Previous studies [1, 10, 25, 26] have shown that the high incidence of Gm(-) strains as the implicated pathogens of ABM is noted especially in those with a preceding post-NS state. This relatively higher number of Gm(-) pathogen was also noted in a previous study of ABM with mixed infection reported by Chang et al., in 2000, [4] in which Enterobacter spp., Es. coli, and Klebsiella spp. were the common Gm(-) pathogens. In present study, Es. coli, Pseudomonas spp., Acinetobacter spp., and Klebsiella spp. were the most common. This change of relative frequency of implicated Gm(-) pathogens should deserve special mention because a development of resistance to the commonly used 3 rd or 4 th generation cephalosporin in the treatment of ABM or the development of multi-drug resistance strains has been noted in these main Gm(-) pathogens. [27] [28] [29] [30] This development may cause a great difficulty in the choice of appropriate antibiotics and result in a therapeutic challenge of this specific of ABM.
Meanwhile, except En. cloacae and P. mirabilis, the other implicated Gm(-) pathogens including B. diminuta, E. meningoseptica, A. faecalis, C. acidovorans, and S. putrefaciens are all uncommon pathogens of ABM [1, 2] and were not found in our previous study of ABM with mixed infection. [4] Among these uncommon Gm(-) pathogens, B. diminuta and C. acidovorans belong to Pseudomonas rRNA homology groups II and III, respectively, [31, 32] while E. meningoseptica, A. faecalis, and S. putrefaciens belong to non-fermentative Gm(-) rods. [33] [34] [35] These uncommon strains are usually becoming pathogenic in specific groups of patients, especially in those with malignancy and other immunocompromised states. The treatment of these uncommon Gm(-) pathogens associated bacterial meningitis also needs special consideration because most of them are not susceptible to the common antibiotics, such as 3 rd generation cephalosporins, used in the treatment of ABM. [31] [32] [33] [34] [35] [36] Gm(+) pathogens including Staphylococcus, Streptococcus, and Enterococcus spp. accounted for 24% (11/45) of the implicated pathogens of this study. These Gm(+) strains are also common pathogens of ABM in Taiwan, [1, 17, 37, 38] and their infections are usually associated with ABM patients with a preceding post-NS state. All these Gm(+) strains found in post-NS ABM usually have a high incidence of antimicrobial resistance, and this finding was also noted in this study [ Table 3 ]. For Gm(+) pathogen-related ABM treatment, vancomycin or linezolid is usually the drug of choice. In our hospital, vancomycin is chosen as the initial empiric antibiotic used in the treatment of adult patients with highly suspected acute bacterial meningitis; therefore, so far, the choice of appropriate antibiotic in ABM related to these Gm(+) pathogens is usually not a therapeutic (4/45) of the implicated bacterial pathogens of post-NS ABM with mixed infection. These anaerobic pathogens are uncommonly found in ABM, [1, 4] and usually occur in specific groups of patients. [39] [40] [41] [42] [43] [44] However, their emergence as the pathogenic strains of post-NS ABM deserves special mention because they need different antimicrobial agents such as metronidazole, carbapenems, and a combination of penicillin and beta-lactamase inhibitor for therapeutic consideration. [40] [41] [42] [43] [44] [45] Bacterial meningitis is a serious complication of Post-NS state, and these concomitant situations are ensured a high morbidity and mortality. [10, 14] The high mortality rate (36/151, 23.8%) [ Table 5 ] of this specific group of ABM cases was also noted in this study, in which those with a mixed infection had a higher rate (33.3%, 6/18) than those with a monomicrobial infection (22.6%, 30/133), although this difference did not reach a statistical significance. As shown in Table 1 , cases 2, 7, and 13 had anaerobic pathogen infection, but none of them had brain abscess. Case 7 died in the therapeutic course; i.e., in present study, the mortality rate (1/3, 33.3%) of patients with anaerobic pathogen infection was not higher than that (6/18, 33.3%) of the overall cases. As also shown in Table 4 , no significant prognostic factor was found between the fatal and non-fatal cases of post-NS ABM with mixed infection. In a large-scale study of risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 post-NS patients reported by Federico et al., the mortality rate was 8% and the predictors of mortality included low CSF glucose concentration, increased value of the Acute Physiology and Chronic Health Evaluation (APACHE) III score, and Gm(-) pathogen infection. [46] In this study, as shown in Table 1 , four (cases 1, 12, 15, and 16) of the eight ABM cases with a pure Gm(-) pathogen-related infection died (50%), while only two (cases 3 and 7) of the other 10 ABM cases with a mixed Gm(-) and Gm(+) pathogen-related mixed infection died (20%); but the case number of different pathogen combinations is too small to draw a prognostic conclusion. Many factors including primary brain pathology, delayed diagnosis, a delay in using appropriate antibiotics, and the serious complications of bacterial meningitis may influence the therapeutic result of post-NS ABM, [1, 2, 6, 7, 10, 14] and the reported therapeutic results (including the mortality rate) varied greatly between different study reports of adult nosocomial and/or post-NS ABM. [1, 5, 10, 14, 16, [24] [25] [26] 46] Clinically, it is difficult to compare the mortality rates reported by the different studies of ABM because different patient groups (e.g., difference in age and difference in implicated pathogens) were enrolled and different therapeutic regimens were used. [1, 5, 10, 14, 16, [24] [25] [26] 46] Although the mortality rate shown in the report of Federico et al., [46] was lower than that of the present study, it is difficult to make a comparative analysis of the mortality rates because of the following: (1) the difference in enrolled age groups and (2) the difference in the prevalence of implicated pathogens [Gm(+) vs. Gm(-)]. In addition, mixed infection was not the main issue of the study reported by Federico et al., [46] In this study of post-NS ABM with mixed infection, the presence of multiple pathogens-related infection and their high incidence of antibiotic resistance may make the situation more complicated. Nevertheless, further large-scale study is needed for a better delineation of the prognostic factors of this specific ABM syndrome.
In conclusion, mixed infection is not uncommon in post-NS ABM (10.6%) and the mortality rate (33.3%) is high in this specific ABM syndrome. Seventy-six percent of the implicated bacterial pathogens of post-NS ABM with mixed infection belonged to Gm(-) strains, while the other 24% belonged to Gm(+) strains. Among the implicated Gm(-) pathogens, uncommon Gm(-) strains for ABM and anaerobic strains have appeared and their presence needs special consideration in the choice of appropriate antimicrobial agents for treatment. The clinical and laboratory features of ABM with mixed infection are not unique; its diagnosis can only be made by a positive CSF culture and a high suspicion of this specific infectious syndrome, especially in those with a preceding post-NS state, is important for its early identification.
